Literature DB >> 29948632

Mitochondrial genome analysis in penile carcinoma.

L F Araujo1,2, A T Terra3, C T G Sares3, C F R Sobreira4, E F Faria5, R D Machado5, A A Rodrigues3, V F Muglia6, W A Silva1,2,7, R B Reis8,9,10.   

Abstract

Penile cancer is a rare neoplasm that seems to be linked to socio-economic differences. Mitochondrial genome alterations are common in many tumors types and are reported as regulating oxidative metabolism and impacting tumorigenesis. In this study, we evaluate for the first time the mitochondrial genome in penile carcinoma (PeCa), aiming to evaluate heteroplasmy, mitochondrial DNA (mtDNA) mutational load and mtDNA content in Penile tumors. Using next generation sequencing (NGS), we sequenced the mitochondrial genome of 13 penile tumors and 12 non-neoplastic tissue samples, which allowed us to identify mtDNA variants and heteroplasmy. We further evaluated variant's pathogenicity using Mutpred predictive software and calculated mtDNA content using quantitative PCR. Mitochondrial genome sequencing revealed an increase number of non-synonymous variants in the tumor tissue, along with higher frequency of heteroplasmy and mtDNA depletion in penile tumors, suggesting an increased mitochondrial instability in penile tumors. We also described a list of mitochondrial variants found in penile tumor and normal tissue, including five novel variants found in the tumoral tissue. Our results showed an increased mitochondrial genome instability in penile tumors. We also suggest that mitochondrial DNA copy number (mtDNAcn) and mtDNA variants may act together to imbalance mitochondrial function in PeCa. The better understanding of mitochondrial biology can bring new insights on mechanisms and open a new field for therapy in PeCa.

Entities:  

Keywords:  Heteroplasmy; Mitochondrial genome; MtDNA copy number; Mutation; Penile carcinoma

Mesh:

Substances:

Year:  2018        PMID: 29948632     DOI: 10.1007/s11033-018-4197-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  27 in total

1.  Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects.

Authors:  Andrew R Mullen; Zeping Hu; Xiaolei Shi; Lei Jiang; Lindsey K Boroughs; Zoltan Kovacs; Richard Boriack; Dinesh Rakheja; Lucas B Sullivan; W Marston Linehan; Navdeep S Chandel; Ralph J DeBerardinis
Journal:  Cell Rep       Date:  2014-05-22       Impact factor: 9.423

2.  Mitochondrial genome instability in colorectal adenoma and adenocarcinoma.

Authors:  Luiza F de Araujo; Aline S Fonseca; Bruna R Muys; Jessica R Plaça; Rafaela B L Bueno; Julio C C Lorenzi; Anemari R D Santos; Greice A Molfetta; Dalila L Zanette; Jorge E S Souza; Valeria Valente; Wilson A Silva
Journal:  Tumour Biol       Date:  2015-06-12

3.  Mitochondrial ND1 Variants in 1281 Chinese Subjects With Leber's Hereditary Optic Neuropathy.

Authors:  Yanchun Ji; Min Liang; Juanjuan Zhang; Ling Zhu; Zengjun Zhang; Runing Fu; Xiaoling Liu; Minglian Zhang; Qun Fu; Fuxin Zhao; Yi Tong; Yanhong Sun; Pingping Jiang; Min-Xin Guan
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-05-01       Impact factor: 4.799

4.  mtDNA Variation and Analysis Using Mitomap and Mitomaster.

Authors:  Marie T Lott; Jeremy N Leipzig; Olga Derbeneva; H Michael Xie; Dimitra Chalkia; Mahdi Sarmady; Vincent Procaccio; Douglas C Wallace
Journal:  Curr Protoc Bioinformatics       Date:  2013-12

Review 5.  Mitochondrial diabetes mellitus: a review.

Authors:  K D Gerbitz; J M van den Ouweland; J A Maassen; M Jaksch
Journal:  Biochim Biophys Acta       Date:  1995-05-24

6.  ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.

Authors:  Kaori Ishikawa; Keizo Takenaga; Miho Akimoto; Nobuko Koshikawa; Aya Yamaguchi; Hirotake Imanishi; Kazuto Nakada; Yoshio Honma; Jun-Ichi Hayashi
Journal:  Science       Date:  2008-04-03       Impact factor: 47.728

7.  Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.

Authors:  Siraj M Ali; Sumanta K Pal; Kai Wang; Norma A Palma; Eric Sanford; Mark Bailey; Jie He; Julia A Elvin; Juliann Chmielecki; Rachel Squillace; Edward Dow; Deborah Morosini; Jamie Buell; Roman Yelensky; Doron Lipson; Garrett M Frampton; Peter Howley; Jeffrey S Ross; Philip J Stephens; Vincent A Miller
Journal:  Oncologist       Date:  2015-12-15

8.  Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers.

Authors:  Hellen Kuasne; Ilce Mara de Syllos Cólus; Ariane Fidelis Busso; Hector Hernandez-Vargas; Mateus Camargo Barros-Filho; Fabio Albuquerque Marchi; Cristovam Scapulatempo-Neto; Eliney Ferreira Faria; Ademar Lopes; Gustavo Cardoso Guimarães; Zdenko Herceg; Silvia Regina Rogatto
Journal:  Clin Epigenetics       Date:  2015-04-18       Impact factor: 6.551

9.  Mitochondrial DNA copy number variation across human cancers.

Authors:  Ed Reznik; Martin L Miller; Yasin Şenbabaoğlu; Nadeem Riaz; Judy Sarungbam; Satish K Tickoo; Hikmat A Al-Ahmadie; William Lee; Venkatraman E Seshan; A Ari Hakimi; Chris Sander
Journal:  Elife       Date:  2016-02-22       Impact factor: 8.140

Review 10.  Penile cancer: epidemiology, pathogenesis and prevention.

Authors:  M C G Bleeker; D A M Heideman; P J F Snijders; S Horenblas; J Dillner; C J L M Meijer
Journal:  World J Urol       Date:  2008-07-08       Impact factor: 3.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.